Search Results

There are 3043 results for: content related to: Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies

  1. You have free access to this content
    Darbepoetin for the anaemia of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Jonathan C Craig, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 31 MAR 2014, DOI: 10.1002/14651858.CD009297.pub2

  2. Erythropoietin or darbepoetin for patients with cancer

    Intervention Review

    The Cochrane Library

    Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert and Julia Bohlius

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD003407.pub5

  3. You have free access to this content
    Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Dimitris Mavridis, Georgia Salanti, Jonathan C Craig, Marcello Tonelli, Natasha Wiebe and Giovanni FM Strippoli

    Published Online : 8 DEC 2014, DOI: 10.1002/14651858.CD010590.pub2

  4. You have free access to this content
    Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

    British Journal of Haematology

    Volume 122, Issue 3, August 2003, Pages: 394–403, Michael Hedenus, Magnus Adriansson, Jesus San Miguel, Mark H. H. Kramer, Martin R. Schipperus, Eeva Juvonen, Kerry Taylor, Andrew Belch, Albert Altés, Giovanni Martinelli, David Watson, James Matcham, Gregory Rossi and Timothy J. Littlewood

    Version of Record online : 23 JUL 2003, DOI: 10.1046/j.1365-2141.2003.04448.x

  5. Darbepoetin alfa: An Effective Treatment with Flexible and Simplified Dosing for Anemia in Patients with Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 3, March 2007, Pages: 434–446, Dr. James G. Stevenson and James J. Natale

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.3.434

  6. Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis

    The Journal of Clinical Pharmacology

    Volume 50, Issue S9, September 2010, Pages: 75S–90S, Sameer Doshi, Andrew Chow and Juan José Pérez Ruixo

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010377201

  7. Evaluation of the US Oncology Network's Recommended Guidelines for Therapeutic Substitution with Darbepoetin alfa 200 μg Every 2 Weeks in Both Naïve Patients and Patients Switched from Epoetin alfa

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 3, March 2004, Pages: 313–323, William A. Thames, Sandra L. Smith, Andrew C. Scheifele, Bin Yao, Suzana A. Giffin and Julie L. Alley

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.4.313.33180

  8. Dose Conversion from Recombinant Human Erythropoietin to Darbepoetin alfa: Recommendations From Clinical Studies

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 9P2, September 2002, Pages: 160S–165S, Shane D. Scott

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.14.160S.33398

  9. Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia

    Nephrology

    Volume 7, Issue 6, December 2002, Pages: 315–323, Amgen Anaemia Advisory Group

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1440-1797.2002.00133.x

  10. Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open-label, Australian study

    Nephrology

    Volume 12, Issue 1, February 2007, Pages: 95–101, ALEX DISNEY, PETER DE JERSEY, GEOFF KIRKLAND, MURTY MANTHA, JOHN A CHARLESWORTH, MARTIN GALLAGHER, DAVID HARRIS, HILTON GOCK, GEORGE J MANGOS, JAMIE MACMILLAN, WEI LIU and AJIT VISWALINGAM

    Version of Record online : 8 FEB 2007, DOI: 10.1111/j.1440-1797.2006.00757.x

  11. You have free access to this content
    Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia

    American Journal of Hematology

    Volume 85, Issue 9, September 2010, Pages: 655–663, Michael Auerbach, Peter T. Silberstein, R. Timothy Webb, Svetlana Averyanova, Tudor-Eliade Ciuleanu, James Shao and Kenneth Bridges

    Version of Record online : 4 JUN 2010, DOI: 10.1002/ajh.21779

  12. You have free access to this content
    Physical and biophysical effects of polysorbate 20 and 80 on darbepoetin alfa

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 9, September 2009, Pages: 3200–3217, Songpon Deechongkit, Jie Wen, Linda O. Narhi, Yijia Jiang, Sungae S. Park, Justin Kim and Bruce A. Kerwin

    Version of Record online : 22 APR 2009, DOI: 10.1002/jps.21740

  13. Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia

    Nephrology

    Volume 7, Issue s2, May 2002, Pages: S173–S180, Amgen Anaemia Advisory Group

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1797.2002.tb00530.x

  14. You have free access to this content
    An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis

    Journal of Internal Medicine

    Volume 260, Issue 6, December 2006, Pages: 577–585, A. K. AGARWAL, M. R. SILVER, J. E. REED, R. K. DHINGRA, W. LIU, N. VARMA and C. STEHMAN-BREEN

    Version of Record online : 16 NOV 2006, DOI: 10.1111/j.1365-2796.2006.01723.x

  15. Darbepoetin alfa, a New Therapy for the Management of Anemia of Chronic Kidney Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 9P2, September 2002, Pages: 141S–149S, Joanna Q. Hudson and Roya M. Sameri

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.14.141S.33397

  16. Guidelines for Using Darbepoetin alfa in Patients with Chemotherapy-Induced Anemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 12P2, December 2003, Pages: 110S–118S, Mr. Michael Bloomfield, Dr. George Jaresko, Mr. John Zarek and Dr. Nicki Dozier

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.23.16.110S.31970

  17. An Overview of the Pharmacokinetic Disposition of Darbepoetin alfa

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 9P2, September 2002, Pages: 133S–140S, Dr. William C. Zamboni and Dr. Clinton F. Stewart

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.14.133S.33396

  18. Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia

    Pediatric Blood & Cancer

    Volume 49, Issue 5, 15 October 2007, Pages: 687–693, Jeffrey Blumer, Stacey Berg, Peter C. Adamson, Thomas Loew, Greg Rossi and Caroline Hastings

    Version of Record online : 21 NOV 2006, DOI: 10.1002/pbc.21079

  19. You have free access to this content
    Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients

    Intervention Review

    The Cochrane Library

    Deirdre Hahn, June D Cody and Elisabeth M Hodson

    Published Online : 28 MAY 2014, DOI: 10.1002/14651858.CD003895.pub3

  20. You have free access to this content
    A Retrospective Assessment of Pre-Treatment Variables on the Response to Darbepoetin Alfa After Renal Transplantation

    American Journal of Transplantation

    Volume 5, Issue 8, August 2005, Pages: 1948–1956, Lisa M. McDevitt, Lonnie D. Smith, K. T. Somerville, Jacke L. Corbett and Fuad S. Shihab

    Version of Record online : 13 JUN 2005, DOI: 10.1111/j.1600-6143.2005.00941.x